1362
CONCLUSION: The new quinolone derivatives (levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin), also called gyrase inhibitors, are known for their potential to cause central nervous system-related adverse effects, including headache, dizziness and insomnia.
 ( adverse event: cause ,  central nervous system-related adverse effects, including headache, dizziness and insomnia: Effect, The new quinolone derivatives (levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin), also called gyrase inhibitors: Treatment, levofloxacin: Treatment.Drug, sparfloxacin: Treatment.Drug, grepafloxacin: Treatment.Drug, trovafloxacin: Treatment.Drug, gatifloxacin: Treatment.Drug, moxifloxacin: Treatment.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: cause ,  central nervous system-related adverse effects, including headache, dizziness and insomnia: Effect, The new quinolone derivatives (levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin), also called gyrase inhibitors: Treatment, levofloxacin: Treatment.Drug, sparfloxacin: Treatment.Drug, grepafloxacin: Treatment.Drug, trovafloxacin: Treatment.Drug, gatifloxacin: Treatment.Drug, moxifloxacin: Treatment.Drug) 